Education
About Us
Working with TipRanks
Follow Us
Champions Oncology (CSBR)
NASDAQ:CSBR
Total Valuation
Champions Oncology has a market cap or net worth of $94.30M. The enterprise value is $91.09M.
Market Cap$94.30M
Enterprise Value$91.09M
Share Statistics
Champions Oncology has 13,886,326 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,886,326
Owned by Insiders14.82%
Owned by Institutions32.17%
Financial Efficiency
Champions Oncology’s return on equity (ROE) is 1.25 and return on invested capital (ROIC) is 46.44%.
Return on Equity (ROE)1.25
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)46.44%
Return on Capital Employed (ROCE)0.54
Revenue Per Employee271.16K
Profits Per Employee22.39K
Employee Count210
Asset Turnover1.76
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Champions Oncology is 40.8. Champions Oncology’s PEG ratio is -0.13.
PE Ratio40.8
PS Ratio1.72
PB Ratio25.89
Price to Fair Value25.89
Price to FCF13.96
Price to Operating Cash Flow16.00
PEG Ratio-0.13
Income Statement
In the last 12 months, Champions Oncology had revenue of 56.94M and earned 4.70M in profits. Earnings per share was 0.34.
Revenue56.94M
Gross Profit26.91M
Operating Income4.85M
Pretax Income4.63M
Net Income4.70M
EBITDA6.29M
Earnings Per Share (EPS)0.34
Cash Flow
In the last 12 months, operating cash flow was 6.22M and capital expenditures -583.00K, giving a free cash flow of 5.64M billion.
Operating Cash Flow6.22M
Free Cash Flow5.64M
Free Cash Flow per Share0.41
Dividends & Yields
Champions Oncology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.42
52-Week Price Change-25.94%
50-Day Moving Average6.70
200-Day Moving Average6.97
Relative Strength Index (RSI)50.88
Average Volume (3m)17.98K
Important Dates
Champions Oncology upcoming earnings date is Mar 17, 2026, After Close (Confirmed).
Last Earnings DateDec 15, 2025
Next Earnings DateMar 17, 2026
Ex-Dividend Date―
Financial Position
Champions Oncology as a current ratio of 0.94, with Debt / Equity ratio of 126.35%
Current Ratio0.94
Quick Ratio0.94
Debt to Market Cap0.00
Net Debt to EBITDA-0.57
Interest Coverage Ratio168.63
Taxes
In the past 12 months, Champions Oncology has paid -75.00K in taxes.
Income Tax-75.00K
Effective Tax Rate-0.02
Enterprise Valuation
Champions Oncology EV to EBITDA ratio is 14.49, with an EV/FCF ratio of 13.43.
EV to Sales1.65
EV to EBITDA14.49
EV to Free Cash Flow13.43
EV to Operating Cash Flow12.73
Balance Sheet
Champions Oncology has $8.52M in cash and marketable securities with $5.27M in debt, giving a net cash position of $3.25M billion.
Cash & Marketable Securities$8.52M
Total Debt$5.27M
Net Cash$3.25M
Net Cash Per Share$0.23
Tangible Book Value Per Share$0.25
Margins
Gross margin is 32.83%, with operating margin of 8.00%, and net profit margin of 8.26%.
Gross Margin32.83%
Operating Margin8.00%
Pretax Margin8.12%
Net Profit Margin8.26%
EBITDA Margin11.39%
EBIT Margin8.51%
Analyst Forecast
The average price target for Champions Oncology is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$12.00
Price Target Upside80.72% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast9.06%
EPS Growth Forecast―